“You will never fight a virus with hate and discrimination”
InterviewAn interview with Evghenii Golosceapov, Director of Advocacy at Positive Initiative, a Moldovan NGO and partner of the Make Medicines...
Read more about “You will never fight a virus with hate and discrimination”
-
Gilead sues Russia: Private company challenges a country’s right to protect public health
NewsIn January this year, the Russian Federation took decisive action, to put public health before the profit of private companies,...
-
Russian Federation’s updated patent law puts public health first
NewsThe Russian Federation parliament voted this week (13 April 2021) to enshrine into the law the country’s right to enact...
Read more about Russian Federation’s updated patent law puts public health first
-
Russian government issues its first health-related compulsory license
NewsA new year signals a new approach to access to medicines in the Russian Federation. Remdesivir, a drug patented by...
Read more about Russian government issues its first health-related compulsory license
-
Russian government advised – “issue compulsory license to make generic COVID-19 drug available”
Call to action NewsFirst civil society, and now a generic drug company, have asked the Russian government to issue a compulsory license on...
-
Russian patient organizations ask Gilead to disclaim patents for Truvada
Call to action NewsOn 3 September 2020, 25 patient organizations working within the HIV response in Russia published an open letter to Gilead...
Read more about Russian patient organizations ask Gilead to disclaim patents for Truvada
-
Report: 10 years of community-monitoring of ARV procurement in Russia
News ResearchITPCru has released its latest report, providing a yearly analysis of community-monitoring of ARV procurement. The 2019 report marks 10...
Read more about Report: 10 years of community-monitoring of ARV procurement in Russia
-
Russian NGOs oppose Gilead’s patent for HIV drug, Truvada
NewsHumanitarian Action with technical support from ITPCru has opposed Gilead’s patent in Russia for the combination of two antiretroviral drugs,...
Read more about Russian NGOs oppose Gilead’s patent for HIV drug, Truvada
-
Letter to ViiV Healthcare: No more time to waste – increase access to dolutegravir in Eastern Europe and Central Asia
News Press releaseDolutegravir is an essential drug in HIV treatment, recommended by the World Health Organization (WHO). Despite the drug being approved...
